Toward Artificial Immunotoxins: Traceless Reversible Conjugation of RNase A with Receptor Targeting and Endosomal Escape Domains-Reference-Cited by-同舟云学术

Toward Artificial Immunotoxins: Traceless Reversible Conjugation of RNase A with Receptor Targeting and Endosomal Escape Domains

Published:2016-12-07 Issue:5 Volume:14 Page:1439-1449
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Liu Xiaowen¹,Zhang Peng¹²,Rödl Wolfgang¹,Maier Kevin¹,Lächelt Ulrich¹²^ORCID,Wagner Ernst¹²^ORCID

Affiliation:

1. Pharmaceutical Biotechnology, Center for System-based Drug Research and Center for NanoScience (CeNS), Ludwig-Maximilians-Universität München, Butenandtstrasse 5-13, D-81377 Munich, Germany

2. Nanosystems Initiative Munich, Schellingstrasse 4, D-80799 Munich, Germany

Funder

Deutsche Forschungsgemeinschaft

China Scholarship Council

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.6b00701

Reference53 articles.

1. Protein therapeutics: a summary and pharmacological classification

2. Protein delivery into live cells by incubation with an endosomolytic agent

3. Stimuli-responsive nanomaterials for therapeutic protein delivery

4. Development of Multinuclear Polymeric Nanoparticles as Robust Protein Nanocarriers

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemoselective Reagents for the Traceless Bioreversible Modification of Native Proteins;Bioconjugate Chemistry;2024-08-29

2. Smart chemistry for traceless release of anticancer therapeutics;Biomaterials;2023-12

3. Modular Diazo Compound for the Bioreversible Late-Stage Modification of Proteins;Journal of the American Chemical Society;2023-03-15

4. Improving solubility of poorly water-soluble drugs by protein-based strategy: A review;International Journal of Pharmaceutics;2023-03

5. Endosomal escape for cell-targeted proteins. Going out after going in;Biotechnology Advances;2023-03